Rebecca Nzawa Soko

Rebecca Nzawa Soko

Auto-generated profile, based on publicly available information

Rebecca Nzawa Soko

Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2023 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
HFHelena R. A. Feasey
Helena R. A. Feasey
MKMcEwen Khundi
McEwen Khundi
RSRebecca Nzawa Soko
Rebecca Nzawa Soko
ENEmily Nightingale
Emily Nightingale
RBRachael M. Burke
Rachael M. Burke
ECElizabeth L. Corbett
Elizabeth L. Corbett
Recent evidence shows rapidly changing tuberculosis (TB) epidemiology in Southern and Eastern Africa, with need for subdistrict prevalence estimates to guide targeted interventions. We conducted a pulmonary TB prevalence survey to estimate current TB burden in Blantyre city, Malawi. From May 2019 to March 2020, 115 households in middle/high-density residential Blantyre, were randomly-selected from each of 72 clusters. Consenting eligible participants (household residents ≥ 18 years) were interviewed, including for cough (any duration), and offered HIV testing and chest X-ray; participants with cough and/or abnormal X-ray provided two sputum samples for microscopy, Xpert MTB/Rif and mycobacterial culture. TB disease prevalence and risk factors for prevalent TB were calculated using complete-case analysis, multiple imputation, and inverse probability weighting. Of 20,899 eligible adults, 15,897 (76%) were interviewed, 13,490/15,897 (85%) had X-ray, and 1,120/1,394 (80%) sputum-eligible participants produced at least one specimen, giving 15,318 complete cases (5,895, 38% men). 29/15,318 had bacteriologically-confirmed TB (189 per 100,000 complete-case (cc) / 150 per 100,000 with inverse weighting (iw)). Men had higher burden (cc: 305 [95% CI:144–645] per 100,000) than women (cc: 117 [95% CI:65–211] per 100,000): cc adjusted odds ratio (aOR) 2.70 (1.26–5.78). Other significant risk factors for prevalent TB on complete-case analysis were working age (25–49 years) and previous TB treatment, but not HIV status. Multivariable analysis of imputed data was limited by small numbers, but previous TB and age group 25–49 years remained significantly associated with higher TB prevalence. Pulmonary TB prevalence for Blantyre was considerably lower than the 1,014 per 100,000 for urban Malawi in the 2013–14 national survey, at 150–189 per 100,000 adults, but some groups, notably men, remain disproportionately affected. TB case-finding is still needed for TB elimination in Blantyre, and similar urban centres, but should focus on reaching the highest risk groups, such as older men.

5 December 2023 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
HFHelena R. A. Feasey
Helena R. A. Feasey
MKMcEwen Khundi
McEwen Khundi
RSRebecca Nzawa Soko
Rebecca Nzawa Soko
CBChristian Bottomley
Christian Bottomley
LCLingstone Chiume
Lingstone Chiume
ECElizabeth L. Corbett
Elizabeth L. Corbett
Active case-finding (ACF) for tuberculosis can help find the “missing millions” with undiagnosed tuberculosis. In a cluster-randomised trial, we investigated impact of ACF on case-notifications in Blantyre, Malawi, where ACF has been intensively implemented following 2014 estimates of ~1,000 per 100,000 adults with undiagnosed TB. Following a pre-intervention prevalence survey (May 2019 to March 2020), constrained randomisation allocated neighbourhoods to either door-to-door ACF (sputum microscopy for reported cough >2 weeks) or standard-of-care (SOC). Implementation was interrupted by COVID-19. Cluster-level bacteriologically-confirmed case-notification rate (CNR) ratio within 91 days of ACF was our redefined primary outcome; comparison between arms used Poisson regression with random effects. Secondary outcomes were 91-day CNR ratios comparing all tuberculosis registrations and all non-ACF registrations. Interrupted time series (ITS) analysis of CNRs in the SOC arm examined prevalence survey impact. (ISRCTN11400592). 72 clusters served by 10 study-supported tuberculosis registration centres were randomised to ACF (261,244 adults, 58,944 person-years follow-up) or SOC (256,713 adults, 52,805 person-years). Of 1,192 ACF participants, 13 (1.09%) were smear-positive. Within 91 days, 113 (42 bacteriologically-confirmed) and 108 (33 bacteriologically-confirmed) tuberculosis patients were identified as ACF or SOC cluster residents, respectively. There was no difference by arm, with adjusted 91-day CNR ratios 1.12 (95% CI: 0.61–2.07) for bacteriologically-confirmed tuberculosis; 0.93 (95% CI: 0.68–1.28) for all tuberculosis registrations; and 0.86 (95%CI: 0.63–1.16) for non-ACF (routinely) diagnosed. Of 7,905 ACF and 7,992 SOC pre-intervention survey participants, 12 (0.15%) and 17 (0.21%), respectively, had culture/Xpert-confirmed tuberculosis. ITS analysis showed no survey impact on SOC CNRs. Despite residual undiagnosed tuberculosis of 150 per 100,000 population, there was no increase in tuberculosis notifications from this previously successful approach targeting symptomatic disease, likely due to previous TB ACF and rapid declines in TB burden. In such settings, future ACF should focus on targeted outreach and demand creation, alongside optimised facility-based screening. Trial Registration: ISRCTN11400592.

2 September 2021 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
MKMcEwen Khundi
McEwen Khundi
PMPeter MacPherson
Peter MacPherson
HFHelena R. A. Feasey
Helena R. A. Feasey
RSRebeca Nzawa Soko
Rebeca Nzawa Soko
MNMarriott Nliwasa
Marriott Nliwasa
JCJames R. Carpenter
James R. Carpenter
We investigated whether household to clinic distance was a risk factor for death on tuberculosis (TB) treatment in Malawi. Using enhanced TB surveillance data, we recorded all TB treatment initiations and outcomes between 2015 and 2018. Household locations were geolocated, and distances were measured by a straight line or shortest road network. We constructed Bayesian multi-level logistic regression models to investigate associations between distance and case fatality. A total of 479/4397 (10.9%) TB patients died. Greater distance was associated with higher (odds ratio (OR) 1.07 per kilometre (km) increase, 95% credible interval (CI) 0.99–1.16) odds of death in TB patients registered at the referral hospital, but not among TB patients registered at primary clinics (OR 0.98 per km increase, 95% CI 0.92–1.03). Age (OR 1.02 per year increase, 95% CI 1.01–1.02) and HIV-positive status (OR 2.21, 95% CI 1.73–2.85) were also associated with higher odds of death. Model estimates were similar for both distance measures. Distance was a risk factor for death among patients at the main referral hospital, likely due to delayed diagnosis and suboptimal healthcare access. To reduce mortality, targeted community TB screening interventions for TB disease and HIV, and expansion of novel sensitive diagnostic tests are required.

24 March 2021 in medRxiv
Verified
Preprint
Open access
PDF file
RSRebecca Nzawa Soko
Rebecca Nzawa Soko
RBRachael M Burke
Rachael M Burke
HFHelena Ra Feasey
Helena Ra Feasey
WSWakumanya Sibande
Wakumanya Sibande
MNMarriott Nliwasa
Marriott Nliwasa
PMPeter MacPherson
Peter MacPherson
COVID-19 may impact on tuberculosis (TB) diagnosis and care. We analysed a city-wide electronic TB register in Blantyre, Malawi and interviewed TB officers. Malawi had no official “lockdown” but closed schools and borders on 23 - March 2020. In interrupted time series analysis, there was an immediate 35.9% reduction in TB notifications (95% CI 22.0 to 47.3%) in April, which recovered to near pre-pandemic numbers by December 2020, but with 333 (95% CI 291 to 375) fewer cumulative notifications than anticipated. Women and girls were impacted (30.7% fewer cases, 95% CI 28.4 to 33.0%) more than men and boys (20.9% fewer, 95% CI 18.5 to 23.3). Fear of COVID-19 infection, temporary facility closure, inadequate protective equipment and COVID-19 stigma with similar presenting symptoms to TB were mentioned. Public health measures could benefit both TB and COVID-19, but only if diagnostic services remain accessible and are considered safe to attend.

12 February 2026 in PLOS Global Public Health
Verified
Journal Article
Open access
EGElizabeth Di Giacomo
Elizabeth Di Giacomo
ENEmily S. Nightingale
Emily S. Nightingale
PMPeter MacPherson
Peter MacPherson
HFHelena R. A. Feasey
Helena R. A. Feasey
RSRebecca N. Soko
Rebecca N. Soko
KHKatherine C. Horton
Katherine C. Horton
Substantial evidence demonstrates that men have a higher prevalence of tuberculosis (TB) and decreased use of TB services compared to women. Gender roles and norms contribute to these disparities by influencing social and structural determinants, as well as individual behaviours. In this analysis, we investigated attitudes towards gender equitable norms and TB testing behaviours amongst Malawian men and women participating in a prevalence survey conducted before a community-based TB active case finding trial in Blantyre. Attitudes towards equitable gender norms were captured through a modified version of the Gender Equitable Men Scale (GEMS). Gender inequitable views were prevalent among both men (56.1%) and women (55.8%). The association between a composite GEMS score and TB testing history was modelled using logistic regression, accounting for various sociodemographic covariates (age, sex, wealth quantile, education, and HIV status) (OR = 1.12, 95% CI: 0.88-1.42, p = 0.373). Bivariate analysis demonstrated no notable confounding by any covariates and no strong effect modification. While GEMS score had no association with TB testing history among women, men with higher GEMS scores (less gender-equitable views) were more likely to have been tested for TB across age groups. These findings provide a basis for future investigation into the patterns and motives TB behaviours, particularly in older men. Tailored public health strategies may then be implemented to address this important population.

22 July 2026 in medRxiv
Verified
Preprint
Open access
PDF file
RNRebecca Hendrine Nzawa-Soko
Rebecca Hendrine Nzawa-Soko
RSRobert C Stewart
Robert C Stewart
JKJullita Kenala-Malava
Jullita Kenala-Malava
JMJaphet Myaba
Japhet Myaba
MMManson Msiska
Manson Msiska
ACAmelia C Crampin
Amelia C Crampin
Population-based studies of common mental health conditions (anxiety, depression, post-traumatic stress disorder) require measures that are valid in the study context. We set out to validate the Generalised Anxiety Disorder-7 scale (GAD-7), Patient Health Questionnaire-9 (PHQ-9); and Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) in the most widely spoken languages in Malawi (Chichewa and Chitumbuka). We undertook translation, adaptation, and piloting to produce final versions in both languages. We conducted criterion validation of the GAD-7, PHQ-9 and PC-PTSD-5 against reference diagnoses of DSM-5 generalised anxiety disorder, major/minor depressive episode, and PTSD respectively, using the Structured Clinical Interview for DSM-5 (SCID-5). A weighted sample of screened participants had SCID interview and this was adjusted for in the analysis. We recruited convenience samples of women and men from two sites: a rural Chitumbuka-speaking site where 342 were screened and 219 had SCID; and an urban Chichewa-speaking site where 458 were screened and 251 had SCID. In both languages, the measures had acceptable internal consistency (Cronbach’s alpha ≥ 0.75). Regarding convergent validity, PHQ-9 and GAD-7 were highly correlated but PC-PTSD-5 was only weakly/moderately correlated with the other measures. In Confirmatory Factor Analysis, best fit for GAD-7 and PC-PTSD-5 was a 1-factor structure, and for PHQ-9 was a 2-factor structure; there was only partial measurement invariance between the 2 language versions of each measure. Area under the ROC curve (AUC) for GAD-7 detection of generalised anxiety disorder was: Chitumbuka 0.759 (95%CI: 0.634, 0.871); Chichewa 0.868 (95%CI: 0.812, 0.915). AUC for PHQ-9 detection of major depression was: Chitumbuka 0.634 (95%CI: 0.441, 0.869); Chichewa 0.843 (95%CI: 0.721, 0.927). AUC for PHQ-9 detection of minor-or-major depression was: Chitumbuka 0.751 (95%CI: 0.619, 0.865); Chichewa 0.801 (95%CI: 0.714, 0.879). AUC for PC-PTSD-5 detection of PTSD was: Chitumbuka 0.682 (95%CI: 0.519, 0.853); Chichewa 0.741 (95%CI: 0.604, 0.859). In conclusion, GAD-7 and PHQ-9 showed good/acceptable validity, although criterion validity of PHQ-9 for major depression in Chitumbuka was poor. PC-PTSD-5 showed limitations to its validity, indicating need for further development of PTSD measures in Malawi.